semaglutide suffolk ny Injection | Starts at $149/mo Semaglutide NYC Weight Loss Program

Rajesh Dhirmalani, DO, is a gastroenterologist in New Jersey, and medical advisor to Replenza

Unlike traditional weight-loss medications that target single pathways, this innovative peptide works through three different hormone receptors simultaneously, offering a more comprehensive approach to metabolic regulation

A lipid panel showing LDL of 160 mg/dL does

Dosing Protocol Key Considerations for Liraglutide Adolescent approval: Saxenda is FDA-approved for adolescents aged 12 and older with obesity (BMI at or above the 95th percentile for age and sex), making it the incretin-based obesity treatment with the broadest pediatric indication Established safety profile: With more than a decade of post-marketing surveillance data, liraglutide has the longest safety track record among GLP-1 agonists used for weight management Daily dosing: The daily injection requirement is a disadvantage for some patients but an advantage for those who prefer more consistent drug levels and find weekly injections anxiety-provoking Efficacy: Mean weight loss of 5-8% of body weight, lower than semaglutide (15-17%) or tirzepatide (20-26%), which positions liraglutide as a second-line option in this drug class for most adult patients Tirzepatide: Dual GIP/GLP-1 Agonism Tirzepatide (Zepbound for obesity

Since Medicaid is managed at the state level, coverage rules for Ozempic can vary

refer to the BNF and product SmPC for eligibility, dosing, and monitoring requirements